Company intelligence / Profile preview

Tessera Therapeutics

S omerville, Massachusetts, United Statestesseratherapeutics.com ↗

Ownership: Private
Employees: ~500
Development stage: Preclinical

Overview

Tessera Therapeutics has demonstrated preclinical proof-of-concept data using its RNA-based Gene Writers to correct genetic mutations in animal models of several monogenic diseases, including sickle cell disease, alpha‑1 antitrypsin deficiency, phenylketonuria, and Wilson’s disease. The company has also shown the ability to engineer tumor-killing CAR-T cells using its multiplexed approach. No clinical-stage results have been reported as of mid‑2024.[8][9]

Therapeutic areas: OncologyHematologyRare DiseasesMetabolic Disorders
Modalities: Gene Writing™ (proprietary genome engineering)RNA-based gene editing/engineering[9]Non-viral delivery (lipid nanoparticles)[3][9]
Industry: Biotech

Drug pipeline

3 assets

TSRA-196

2 more assets in the full pipeline.

Request access →

Partnerships

Bill & Melinda Gates Foundation(co-funding SCD program )[3 ][6 ]No major pharma partnerships publicly disclosed as of May2025.

Beyond the preview

Go deeper on Tessera Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tessera Therapeutics.

Explore the full profile